Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Molinari

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptorM Gopalakrishnan, L M Monteggia, D J Anderson, et al.
British Journal of Pharmacology|April 1, 2000
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cellsM Gopalakrishnan, E J Molinari, C C Shieh, et al.
European Journal of Pharmacology|May 14, 1999
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell lineT R Miller, R D Taber, E J Molinari, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 24, 2013
Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPAMarcela A Garabalino, Elisa M Heber, Andrea Monti Hughes, et al.
Revista Chilena De Obstetricia Y Ginecologia|January 1, 1980
[Aspects of labor monitoring]S Abujatum, A Adana, S Aitken, et al.
Journal of Medicinal Chemistry|October 1, 1978
2-Pyrrolidinylideneureas, a new class of central nervous system agentsC R Rasmussen, J F Gardocki, J N Plampin, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Archives of Oral Biology|December 1, 2009
Development of a model of tissue with potentially malignant disorders (PMD) in the hamster cheek pouch to explore the long-term potential therapeutic and/or toxic effects of different therapeutic modalitiesElisa M Heber, Andrea Monti Hughes, Emiliano C C Pozzi, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
The design, synthesis and physical chemical properties of novel human vasopressin V2-receptor antagonists optimized for parenteral deliveryM A Ashwell, J F Bagli, T J Caggiano, et al.
Anticancer Research|July 4, 2012
Blood vessel normalization in the hamster oral cancer model for experimental cancer therapy studiesAna J Molinari, Romina F Aromando, Maria E Itoiz, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1996
Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptorM Gopalakrishnan, L M Monteggia, D J Anderson, et al.
British Journal of Pharmacology|April 1, 2000
Pharmacology of human sulphonylurea receptor SUR1 and inward rectifier K(+) channel Kir6.2 combination expressed in HEK-293 cellsM Gopalakrishnan, E J Molinari, C C Shieh, et al.
European Journal of Pharmacology|May 14, 1999
Pharmacological and molecular characterization of ATP-sensitive K+ channels in the TE671 human medulloblastoma cell lineT R Miller, R D Taber, E J Molinari, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 24, 2013
Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPAMarcela A Garabalino, Elisa M Heber, Andrea Monti Hughes, et al.
Revista Chilena De Obstetricia Y Ginecologia|January 1, 1980
[Aspects of labor monitoring]S Abujatum, A Adana, S Aitken, et al.
Journal of Medicinal Chemistry|October 1, 1978
2-Pyrrolidinylideneureas, a new class of central nervous system agentsC R Rasmussen, J F Gardocki, J N Plampin, et al.
British Journal of Pharmacology|January 24, 2003
Pharmacological characterization of a 1,4-dihydropyridine analogue, 9-(3,4-dichlorophenyl)-3,3,6,6-tetramethyl-3,4,6,7,9,10-hexahydro-1,8(2H,5H)-acridinedione (A-184209) as a novelK(ATP) channel inhibitorMurali Gopalakrishnan, Thomas R Miller, Steven A Buckner, et al.
Archives of Oral Biology|December 1, 2009
Development of a model of tissue with potentially malignant disorders (PMD) in the hamster cheek pouch to explore the long-term potential therapeutic and/or toxic effects of different therapeutic modalitiesElisa M Heber, Andrea Monti Hughes, Emiliano C C Pozzi, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
The design, synthesis and physical chemical properties of novel human vasopressin V2-receptor antagonists optimized for parenteral deliveryM A Ashwell, J F Bagli, T J Caggiano, et al.
Anticancer Research|July 4, 2012
Blood vessel normalization in the hamster oral cancer model for experimental cancer therapy studiesAna J Molinari, Romina F Aromando, Maria E Itoiz, et al.
Pageof 8